Trugen Pharmaceuticals is a finished-dose manufacturer based in India. It appears in 7 regulatory filings across 1 regulator, without an active US DMF or CEP on file. Its GMP standing is certified by NAFDAC (NG). Customs aggregates show $230K of exports covering 49 molecules to 3 destinations in 2025.
| Site | FDA FEI |
|---|---|
| Haridwar, Nigeria | Not on file |
| Regulator | Filings | GMP certificates |
|---|---|---|
| NAFDAC (NG) | 7 | 1 |
| Year | Revenue | Exports | Destinations |
|---|---|---|---|
| 2026 YTD | Not reported | $48K | 1 |
| 2025 | Not reported | $230K | 3 |
| 2024 | Not reported | $164K | 2 |
| 2023 | Not reported | $109K | 4 |
Export figures are customs aggregates. We do not publish the identity of any buyer.
Choose your molecules and target markets. Trugen Pharmaceuticals comes back tiered against every other supplier able to file there.
Start for free